Adlai Nortye Group Ltd.

US$10.28As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ANLHealthcare
Country USA
PE (Fwd) •••
TSR 3Y CAGR (11.45%)
Div yield —
ROE (20.23%)
Biotechnology
Beta (5Y) 1.41
PE TTM —
TSR TTM 618.88%
Mkt cap US$662.0M
ROIC (9.48%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$12
14.27%
(41.06%)
Sell 6|4|1|11|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.09
0.09
0.09
0.10
7.49%
3.65%
8.53%
13.05%
Revenue$M
45.31
47.31
47.71
49.16
9.91%
8.36%
9.49%
13.31%
Peers (US$662.0M)
Cap (US$)
PE
820.5M
15.61x
544.3M
4.022x
662.9M
18.20x
Capital
TTM
5Y
10Y
Leveragex
0.363
0.766
0.669
EBIT/Intx
1.624
0.189
0.180
Own earn%
(49.00)
(22.34)
(14.21)
Sh yield%
6.47
30.30
26.84
Owners
Insiders/Inst%
14.95
49.43
Short interest%
0.64
SBC / revenue%
1.21
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
20–29
$1 testx
−0.3
Incr. ROIC%
0